|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.079 AUD | +1.28% |
|
-4.82% | -45.52% |
| 30/04 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
| 30/04 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
ImpediMed Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported revenue was AUD 5.66 million compared to AUD 5.2 million a year ago. Net loss was AUD 10.82 million compared to AUD 8.92 million a year ago.
Basic loss per share from continuing operations was AUD 0.01 compared to AUD 0.01 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -45.52% | 11Cr | |
| +7.87% | 22TCr | |
| +11.83% | 19TCr | |
| +18.87% | 14TCr | |
| +30.03% | 11TCr | |
| +1.37% | 6.53TCr | |
| +14.15% | 5.25TCr | |
| +2.68% | 4.98TCr | |
| +6.60% | 4.34TCr | |
| +1.85% | 3.59TCr |
IMPEDIMED LIMITED 
